Illumina, Inc. (NASDAQ:ILMN – Get Rating) saw a significant increase in short interest in June. As of June 15th, there was short interest totalling 3,430,000 shares, an increase of 38.9% from the May 31st total of 2,470,000 shares. Based on an average trading volume of 1,280,000 shares, the days-to-cover ratio is currently 2.7 days.
Illumina stock traded up $6.68 during midday trading on Monday, reaching $191.04. 41,175 shares of the stock traded hands, compared to its average volume of 1,162,206. The company has a 50-day simple moving average of $233.46 and a two-hundred day simple moving average of $310.07. Illumina has a 12-month low of $180.00 and a 12-month high of $526.00. The firm has a market cap of $30.01 billion, a PE ratio of 41.53, a price-to-earnings-growth ratio of 1.50 and a beta of 1.10. The company has a current ratio of 1.85, a quick ratio of 1.54 and a debt-to-equity ratio of 0.11.
Illumina (NASDAQ:ILMN – Get Rating) last announced its quarterly earnings data on Thursday, May 5th. The life sciences company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.20. The company had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.22 billion. Illumina had a net margin of 15.04% and a return on equity of 8.37%. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.89 EPS. Equities research analysts anticipate that Illumina will post 4.1 earnings per share for the current year.
A number of large investors have recently modified their holdings of ILMN. Norges Bank acquired a new stake in Illumina during the 4th quarter worth $532,645,000. AustralianSuper Pty Ltd acquired a new stake in shares of Illumina in the 1st quarter worth $240,547,000. Castleview Partners LLC acquired a new stake in shares of Illumina in the 4th quarter worth $1,226,000. Baillie Gifford & Co. increased its holdings in shares of Illumina by 2.1% in the 1st quarter. Baillie Gifford & Co. now owns 20,907,058 shares of the life sciences company’s stock valued at $7,304,926,000 after purchasing an additional 426,521 shares in the last quarter. Finally, Select Equity Group L.P. increased its holdings in shares of Illumina by 123.2% in the 4th quarter. Select Equity Group L.P. now owns 749,656 shares of the life sciences company’s stock valued at $285,199,000 after purchasing an additional 413,771 shares in the last quarter. Hedge funds and other institutional investors own 86.62% of the company’s stock.
A number of analysts have commented on the stock. Piper Sandler reduced their target price on shares of Illumina from $460.00 to $360.00 and set a “na” rating for the company in a report on Sunday, May 15th. Cowen reduced their target price on shares of Illumina from $506.00 to $492.00 in a report on Friday, May 6th. StockNews.com initiated coverage on shares of Illumina in a research note on Thursday, March 31st. They issued a “hold” rating for the company. Cowen reduced their price objective on shares of Illumina from $506.00 to $492.00 in a research note on Friday, May 6th. Finally, Citigroup reduced their price objective on shares of Illumina from $400.00 to $325.00 in a research note on Friday, May 6th. Seven analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $435.92.
About Illumina (Get Rating)
Illumina, Inc provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
- Get a free copy of the StockNews.com research report on Illumina (ILMN)
- Using MarketBeat Market Data Tools To Find Strong Stocks in a Bear Market
- Schnitzer Steel Witnesses A Strong Quarter On The Back Of Strong Domestic Demand
- MarketBeat: Week in Review 6/27 – 7/1
- Accolade Moves Higher But Growth Is Slowing
- ZIM Integrated Shipping Services (ZIM): Don’t Miss This Dividend
Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with MarketBeat.com's FREE daily email newsletter.